Global $300 Billion Nanoparticle Drug Delivery Market Opportunity by 2028
18 mai 2022 04h53 HE
|
Research and Markets
Dublin, May 18, 2022 (GLOBE NEWSWIRE) -- The "Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028" report has been added to ResearchAndMarkets.com's offering....
Global Nanomedicine Nanoparticle Nanotechnology Drug Delivery Market 2028
16 mars 2022 07h43 HE
|
KuicK Research
Delhi, March 16, 2022 (GLOBE NEWSWIRE) -- Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028 Report Highlights: Global Nanoparticle Drug Delivery Market...
Worldwide RNA Interference (RNAi) Drug Delivery Industry to 2027 - Players Include Alnylam Pharmaceuticals, Arrowhead Pharmaceuticals and CureVac Among Others
08 mars 2022 07h13 HE
|
Research and Markets
Dublin, March 08, 2022 (GLOBE NEWSWIRE) -- The "Worldwide RNA Interference (RNAi) Drug Delivery" report has been added to ResearchAndMarkets.com's offering. The global RNA interference (RNAi) drug...
Nanoparticle Drug Delivery Market Drug Clinical Trials USD 300 Billion Opportunity
04 mars 2022 03h42 HE
|
KuicK Research
Delhi, March 04, 2022 (GLOBE NEWSWIRE) -- Global Nanoparticle Drug Delivery Market, Dosage, Price and Clinical Pipeline Outlook 2028 Report Highlights: Global Nanoparticle Drug Delivery Market...
Oncology Pharma is Pleased to Welcome New Chairman to Its Scientific Advisory Board
16 févr. 2021 08h00 HE
|
Oncology Pharma, Inc.
SAN FRANCISCO, CA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to announce that Dr. Henry Smith has accepted the role of Chairman of the...